We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
-2.42%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$48.6M
AUM Growth
-$155M
Cap. Flow
-$172M
Cap. Flow %
-354.52%
Top 10 Hldgs %
95.75%
Holding
36
New
14
Increased
–
Reduced
8
Closed
6

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$474K
2
CSV icon
Carriage Services
CSV
+$106K
3
AAPL icon
Apple
AAPL
+$55K
4
PX
Praxair Inc
PX
+$43.6K
5
IWP icon
iShares Russell Mid-Cap Growth ETF
IWP
+$20K

Top Sells

Rank Stock Value
1
TCRT icon
Alaunos Therapeutics
TCRT
+$105M
2
PGEN icon
Precigen
PGEN
+$66.8M
3
SAGE
Sage Therapeutics
SAGE
+$551K
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$63.1K
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$59.8K

Sector Composition

Rank Sector Weight
1 Healthcare 55.02%
2 Energy 9.94%
3 Technology 3.74%
4 Materials 1.29%
5 Consumer Discretionary 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRT icon
1
Alaunos Therapeutics
TCRT
$4.88M
$20.8M 42.8%
16,691
-63,728
-79% -$105M
WPZ
2
DELISTED
Williams Partners L.P.
WPZ
$4.81M 9.9%
172,732
– –
BPTH
3
DELISTED
Bio-Path Holdings Inc
BPTH
$4.75M 9.77%
958
– –
VOO icon
4
Vanguard S&P 500 ETF
VOO
$1.03T
$2.79M 5.75%
14,948
-335
-2% -$63.1K
VEA icon
5
Vanguard FTSE Developed Markets ETF
VEA
$238B
$2.79M 5.74%
75,947
-1,528
-2% -$57.3K
VOE icon
6
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$2.71M 5.57%
31,481
-408
-1% -$35.7K
VWO icon
7
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$2.66M 5.47%
81,323
-1,738
-2% -$59.8K
VDE icon
8
Vanguard Energy ETF
VDE
$10.4B
$2.05M 4.22%
24,690
-524
-2% -$47.8K
TXN icon
9
Texas Instruments
TXN
$253B
$1.75M 3.61%
32,000
– –
VNQ icon
10
Vanguard Real Estate ETF
VNQ
$38.6B
$1.43M 2.93%
17,885
-273
-2% -$21.6K
GMO
11
DELISTED
General Moly, Inc.
GMO
$585K 1.2%
2,922,831
– –
BMY icon
12
Bristol-Myers Squibb
BMY
$130B
$494K 1.02%
+7,180
New +$474K
LXRX icon
13
Lexicon Pharmaceuticals
LXRX
$1.05B
$475K 0.98%
35,714
– –
ARWR icon
14
Arrowhead Research
ARWR
$12.3B
$220K 0.45%
35,817
– –
CSV icon
15
Carriage Services
CSV
$535M
$110K 0.23%
+4,556
New +$106K
AAPL icon
16
Apple
AAPL
$4.41T
$51K 0.1%
+1,924
New +$55K
PX
17
DELISTED
Praxair Inc
PX
$41K 0.08%
+400
New +$43.6K
IWP icon
18
iShares Russell Mid-Cap Growth ETF
IWP
$21B
$20K 0.04%
+430
New +$20K
MSFT icon
19
Microsoft
MSFT
$3.66T
$13K 0.03%
+235
New +$12.4K
COP icon
20
ConocoPhillips
COP
$153B
$11K 0.02%
+228
New +$11.9K
AMP icon
21
Ameriprise Financial
AMP
$49.9B
$10K 0.02%
+93
New +$10.4K
LUV icon
22
Southwest Airlines
LUV
$22B
$9K 0.02%
+200
New +$8.86K
PSX icon
23
Phillips 66
PSX
$90B
$9K 0.02%
+114
New +$9.84K
POR icon
24
Portland General Electric
POR
$5.74B
$4K 0.01%
118
– –
EFX icon
25
Equifax
EFX
$21.2B
$3K 0.01%
29
– –
1
2

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q4 2015 Portfolio in Review

As of Q4 2015, University of Texas/Texas AM Investment Management Co (UTIMCO) held 36 positions worth $48.6M, down 76% from $203M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) withdrew a net $172M in Q4 2015, closing 6 positions and reducing 8 holdings. Its most notable exit was Precigen, an estimated $66.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 89% a quarter earlier, followed by Energy and Technology.

Against the trend, University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Bristol-Myers Squibb worth $494K.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q4 2015 buy was Bristol-Myers Squibb: 7,180 shares worth $494K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q4 2015 reduction was Alaunos Therapeutics, cutting an estimated $105M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Precigen in Q4 2015, selling an estimated $66.8M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 96% of its $48.6M portfolio in Q4 2015.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 14 new positions and closed 6 in Q4 2015.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value fell 76% quarter-over-quarter to $48.6M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2015, filed 5 Feb 2016.